Holen Sie sich die Stockscreener-App
5.07
11.37%
0.5175
Handel nachbörslich:
4.90
-0.17
-3.35%
Schlusskurs vom Vortag:
$4.5525
Offen:
$4.68
24-Stunden-Volumen:
55,961
Relative Volume:
2.10
Marktkapitalisierung:
$56.31M
Einnahmen:
$2.09M
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-7.5672
EPS:
-0.67
Netto-Cashflow:
$-3.64M
1W Leistung:
+31.69%
1M Leistung:
+22.46%
6M Leistung:
-10.79%
1J Leistung:
+111.25%
1-Tages-Spanne:
$4.55
$5.16
1-Wochen-Bereich:
$3.76
$5.16
52-Wochen-Spanne:
$2.22
$9.595
Nutriband Inc Stock (NTRB) Company Profile
Firmenname
Nutriband Inc
Sektor
Branche
Telefon
407 377-6695
Adresse
121 S. ORANGE AVE., ORLANDO
Vergleichen Sie NTRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
5.07 | 56.31M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.11 | 104.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.15 | 78.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
621.29 | 37.15B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.28 | 30.22B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.79 | 27.76B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nutriband Inc Aktie (NTRB) Neueste Nachrichten
Investors ignore increasing losses at Nutriband (NASDAQ:NTRB) as stock jumps 19% this past week - Simply Wall St
Nutriband Inc. Extends Chinese Patent to Macao for AVERSA™ Abuse Deterrent Transdermal Technology - Defense World
Nutriband Issues Letter to Shareholders - GlobeNewswire
Nutriband Expands AVERSA™ Patent to Macao - TipRanks
Nutriband extends Chinese patent to Macao for AVERSA technology - Yahoo Finance
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband (NASDAQ:NTRB) Trading 1.5% Higher – Time to Buy? - Defense World
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRBW Stock News - StockTitan
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRB Stock News - StockTitan
Nutriband Inc. Quarterly Report Highlights Record Revenue - GlobeNewswire
Nutriband Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2024 - Marketscreener.com
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th - The Manila Times
Nutriband to Showcase Revolutionary Abuse-Deterrent Technology at Noble Conference - StockTitan
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - The Manila Times
Nutriband Secures Hong Kong Patent for Abuse-Deterrent Patch Technology, Eyes $200M Market | NTRB Stock News - StockTitan
(NTRB) Technical Pivots with Risk Controls - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Receives Full Patent Approval for AVERSA™ Abuse and Misuse Deterrent Transdermal SystemORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB) has recently disclosed that the Chinese National Intel - Defense World
Nutriband Secures Chinese Patent for AVERSA™ Technology - TipRanks
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - AccessWire
(NTRB) Technical Data - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1%Time to Sell? - MarketBeat
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1% – Here’s What Happened - Defense World
(NTRB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Nutriband receives Costa Rica MoH approval for Mosquito Repellent Patch - TipRanks
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - AccessWire
Objective long/short (NTRB) Report - Stock Traders Daily
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 - AccessWire
Analyzing Sanara MedTech (NASDAQ:SMTI) and Nutriband (NASDAQ:NTRB) - Defense World
Nutriband (NASDAQ:NTRBW) Trading 6.5% Higher - Defense World
Nutriband (NASDAQ:NTRB) Trading 0.7% Higher - MarketBeat
Nutriband (NASDAQ:NTRB) Trading Up 0.7% - Defense World
(NTRB) Trading Signals - Stock Traders Daily
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN
Head to Head Review: Nutriband (NASDAQ:NTRB) and Jin Medical International (NASDAQ:ZJYL) - Defense World
Nutriband secures patent in China for abuse-deterrent patch - Investing.com
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - AccessWire
Nutriband Inc (NTRB-Q) QuotePress Release - The Globe and Mail
Nutriband (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) for Flagship Product - Barchart
The 5 Public Companies Leading the Fight Against Fentanyl — Plus 10 Facts You Should Know - InvestorNews Inc.
Nutriband inks deal to enhance opioid patch safety - Investing.com
Nutriband inks deal to enhance opioid patch safety By Investing.com - Investing.com Canada
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead ProductAversa(TM) Fentanyl Transdermal Patch - AccessWire
Bubble Tea Craze Hits Par Market with New Ninja Bubble Tea Shop - Cornish Stuff
Keith Martell Purchases 1,250 Shares of Nutrien Ltd. (TSE:NTR) Stock - MarketBeat
Nutrien Ltd (NTR) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
NutriLab Joins NeoSpectra LabStore, Expanding Options for Quick On-Site Analysis of Feed and Feed Ingredients - AccessWire
Massachusetts Financial Services Co. MA Has $133.43 Million Stock Position in Nutrien Ltd. (NYSE:NTR) - MarketBeat
PATS previews: Key focus for Nutriment - Pet Business World News
Insider Buying: Nutrien Ltd. (TSE:NTR) Senior Officer Buys 300 Shares of Stock - Defense World
Nutriband Announces Stock Buyback and Advances in Fentanyl Patch Development - TipRanks
NTR’s Q2 earnings predictions: What the experts say - US Post News
Finanzdaten der Nutriband Inc-Aktie (NTRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):